Main page
Kayseri Silk carpet
My friends


Write a comment discuss trimox in the community forums all services a-z drug list drugs & medications diseases & conditions news & articles pill identifier interactions checker drug image search new drug approvals new drug applications fda drug alerts clinical trial results patient care notes medical encyclopedia medical dictionary medical videos - community forums for professionals veterinary drugs drug imprint codes contact us news feeds advertise here recent searches soliris xifaxan procrit rozerem amoxicillin nicotine dextromethorphan clindamycin xolegel nepafenac lantus tindamax viagra xenical zorbtive retin a titralac glucophage relenza nifedipine amaryl flulaval digoxin orthovisc ultane recently approved exelon patch endometrin exforge nuvigil letairis extina divigel torisel xyzal lybrel more.
Miles TS. Dental pain: self-observations by a neurophysiologist. J Endod 1993; 19 12 ; : 613-5. Miranda FJ, Collard EW, Hatch RA. Diagnosis and treatment of pulpal distress. Dent Clin North 1976; 20 2 ; : 285-97. Molander A, Reit C, Dahlen G. Microbiological evaluation of clindamycin as a root canal dressing in teeth with apical periodontitis. Int Endod J 1990; 23 2 ; : 113-8. Mor C, Rotstein I, Friedman S. Incidence of interappointment emergency associated with endodontic therapy. J Endod 1992; 18 10 ; : 509-11. Morse DR, Furst ML, Belott RM, Lefkowitz RD, Spritzer IB, Sideman BH. Infectious flare-ups and serious sequelae following endodontic treatment: a prospective randomized trial on efficacy of antibiotic prophylaxis in cases of asymptomatic pulpalperiapical lesions. Oral Surg Oral Med Oral Pathol 1987; 64 1 ; : 96-109. Morse DR, Esposito JV, Furst ML. Comparison of prophylactic and on-demand diflunisal for pain management of patients having one-visit endodontic therapy. Oral Surg Oral Med Oral Pathol 1990; 69 6 ; : 729-36. Ngeow WC. Self-injecting morphine for toothache? Br Dent J 1996; 180 9 ; : 327. O'Keefe EM. Pain in endodontic therapy: preliminary study. J Endod 1976; 2 10 ; : 315-9. Oguntebi BR, DeSchepper EJ, Taylor TS, White CL, Pink FE. Postoperative pain incidence related to the type of emergency treatment of symptomatic pulpitis. Oral Surg Oral Med Oral Pathol 1992; 73 4 ; : 479-83. Parente SA, Anderson RW, Herman WW, Kimbrough WF, Weller RN. Anesthetic efficacy of the supplemental intraosseous injection for teeth with irreversible pulpitis. J Endod 1998; 24 12 ; : 826-8. Pettiette MT, Wright JT, Trope M. Dentinogenesis imperfecta: endodontic implications. Case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86 6 ; : 733-7. Robertson CJ. Preliminary assessment of Ledermix--a preliminary clinical trial in Great Britain. J Oral Ther Pharmacol 1968; 4 ; : 304-7. Rogers MJ, Johnson BR, Remeikis NA, BeGole EA. Comparison of effect of intracanal use of ketorolac tromethamine and dexamethasone with oral ibuprofen on post treatment endodontic pain. J Endod 1999; 25 5 ; : 381-4. Rud J, Rud V. Surgical endodontics of upper molars: relation to the maxillary sinus and operation in acute state of infection. J Endod 1998; 24 4 ; : 260-1. In the current cocaine epidemic, about 1982, a rapid growth in the number of heavy users occurred. The ratio L : H fell from 10 : 1 just five years and moved furthermore down to 4 : and this changed the nature of the cocaine $ $ epidemic drastically. The equilibrium ratio, L : H 2.8 : 1 is improvement compared to the last years, where it even fell down to 1.8 : 1 in 1992 and 1993 The National Drug Control Strategy: 1996. Click here to read about the fraud of eli lilly, one of the worst offenders in the field of drugging america, for example, clindamycin dosing.
ANTIRETROVIRALS NRTIs- abacavir Ziagen ; , abacavir lamivudine Epzicom ; , abacavir lamivudine zidovudine Trizivir ; , didanosine ddI, Videx, Videx EC ; , emtricitabine Emtriva ; , lamivudine Epivir, 3TC ; , lamivudine zidovudine Combivir ; , stavudine d4T, Zerit ; , tenofovir emtricitabine Truvada ; , zalcitabine ddC, Hivid ; , zidovudine AZT, Retrovir ; . PIs- amprenavir Agenerase ; , atazanavir Reyataz ; , fosamprenavir Lexiva ; , indinavir Crixivan ; , lopinavir ritonavir Kaletra ; , nelfinavir Viracept ; , ritonavir Norvir ; , saquinavir Fortovase, Invirase ; . NNRTIs- delavirdine Rescriptor ; , efavirenz Sustiva ; , nevirapine Viramune ; . Other- hydroxyurea Hydrea ; . Entry Inhibitorsenfuvirtide Fuzeon ; . OI DRUGS PHS "A1 OI"s- acyclovir Zovirax ; , amphotericin B Fungizone ; , azithromycin Zithromax ; , cidofovir Vistide ; , clarithromycin Biaxin ; , clindamycin phosphate Cleocin Phosphate ; , famciclovir Famvir ; , fluconazole Diflucan ; , isoniazid INH ; , itraconazole Sporonox ; , leucovorin Folinic Acid ; , pentamidine Nebupent, Pentam ; , pyrazinamide, pyrimethamine Daraprim ; , rifabutin Mycobutin ; , rifampin Rifadin, Rifater, Rimactane ; , sulfadiazine, TMP SMX Bactrim, C0-Trimoxazole, Septra, Sulfatrim ; , valacyclovir hydrochloride Valtrex ; , valganciclovir Valcyte ; . Other OIs- amoxicillin Amoxil, Trimox, Wymox ; , atovaquone Mepron ; , cephalexin monohydrate Keflex ; , ciprofloxacin Cipro ; , clindamycin HCL Cleocin HCL ; , clindamycin palmitate Cleocin pediatirc ; , clotrimazole Mycelex, Lotrimin ; , dapsone DDS ; , dicloxacillin sodium Dycill, Dynapen, Pathocil ; , ethambutol Myambutol ; , ketoconazole Nizoral ; , miconazole Monistat ; , nystatin Mycostatin ; , ofloxacin Floxin ; , paromomycin sulfate Humatin ; , primaquine phosphate, streptomycin sulfate, sulfamethoxazole Gantanol, Urobak ; , terconazole Terazol 3, 7 ; , trimethoprim TMP, Proloprim, Trimpex ; . Continued.
Were incubated overnight; blood agar and neomycinblood agar plates were incubated for 48 hours at 37C. Beta-hemolytic streptococci were identified to species level by standard techniques. Other organisms were identified to genus level only. Antibiotic sensitivities of isolates were assessed by disc testing Stokes method ; . The a priori hypothesis of the study was that there would be a reduction in the percentage of histologic chorioamnionitis in the treatment group. A power calculation indicated that 60 women in each of the treatment and placebo arms would detect a difference of 24% in the percentage of women having histologic chorioamnionitis, decreasing from 50% in the placebo group1 to 26% in the treatment group, with 80% power and a 5% significance level. The proportion of women with placental inflammation was compared between the clindamycin and placebo groups using the 2 test, and pregnancy outcomes were compared between women with and without inflammation by Fisher exact test due to small numbers. Logistic regression was used to adjust the relationship between inflammation and treatment group for possible confounding factors and to adjust the relationship between inflammation and pregnancy outcome for treatment group having first collapsed outcome into 2 categories: spontaneous preterm delivery or miscarriage compared with all other outcomes and clobetasol.
CILOXAN oint .42 cimetidine .31 cimetidine inj .31 CIPRO inj . 9 CIPRO susp. 9 CIPRO XR . 9 ciprofloxacin . 9, 42 ciprofloxacin ext-rel . 9 ciprofloxacin inj . 9 cisplatin .15 citalopram .21 cladribine .14 clarithromycin . 9 clarithromycin ext-rel . 9 clemastine 2.68 mg .37 CLEOCIN caps 75 mg .12 CLEOCIN PEDIATRIC .12 CLEOCIN vaginal supp .33 CLIMARA PRO .29 clindamycin .12 clindamycin gel, lotion, soln .39 clindamycin inj .12 clindamycin vaginal crm .33 clobetasol propionate crm, oint 0.05%.41 clomipramine . 20, 21 clonidine .16 clopidogrel.34 clotrimazole .39 clotrimazole troches .10 CLOZAPINE 12.5 mg, 200 mg.22 clozapine 25 mg, 50 mg, 100 mg.22 codeine acetaminophen. 7 COGENTIN inj .22 colchicine . 7 colchicine inj . 7 colestipol.17 COMBIPATCH .29 COMBIVENT .36 COMBIVIR .10 COMTAN.22 COPAXONE .24 COREG.18 CORTEF 5 mg, 10 mg .29 COSMEGEN.14 COSOPT .43 COUMADIN .33 COZAAR .17 CREON .32 CRESTOR .18.
2. Services Included in Facility Cost.--The rate for an ASC surgical procedure includes all facility services directly related to the procedure that are provided on the day of surgery. In general, facility services include, but are not limited to, nursing and technician services, use of the facility, drugs, biologicals, surgical dressings, splints, casts and equipment directly related to provision of the surgical procedure, materials for anesthesia, administrative, recordkeeping and housekeeping items and services. Facility services do not include items and services such as physicians' services, laboratory, Xrays, or diagnostic procedures other than those directly related to the performance of the surgical procedure ; , prosthetic devices, ambulance services, leg, arm, back, and neck braces, artificial limbs, and DME for use in the patient's home. Separate payment is not made for the following services directly related to the surgery. Services reported under the following revenue codes where an ASC covered procedure is reported ; are subject to the ASC payment limitation. a. Use of Hospital Facilities by the Patient.--This includes operating and recovery rooms, patient preparation areas, waiting rooms, and other areas used by the patient or offered for use to the patient's relatives in connection with surgical procedures. It includes all services in connection with covered procedures furnished by nurses, technical personnel, and others involved in patient care. Whenever a surgical procedure is performed, use one or more of the following revenue codes to reflect the charges for items and services provided in connection with the procedure: o 25x Pharmacy; o 270 Medical Surgical Supplies-Devices General o 272 Sterile Supply; o 276 Intraocular Lens; o 36x Operating Room Services; o 37x Anesthesia; o 38x Blood; o 39x Blood Storage and Processing; o 45x Emergency Room; o 49x Ambulatory Surgical Care; o 51x Clinic; o 52x Free-Standing Clinic; o 70x Cast Room; o 71x Recovery Room; o 75x Gastro-Intestinal Services; o 760 Treatment or Observation Room General o 761 Treatment Room; o 769 Other Treatment Room; o 920 Other Diagnostic Services General; o 929 Other Diagnostic Services, Other codes 921-925 are excluded and may be used to report nonfacility services o 940 Other Therapeutic Services, General; and o 949 Other Therapeutic Services, Other codes 941-945 are excluded and may be used to report nonfacility services ; . These revenue codes include diagnostic or therapeutic items and services furnished by your staff in connection with a covered ASC surgical procedure. All services provided in conjunction with surgery, including simple diagnostic tests such as urinalysis and blood hemoglobin and hematocrit, must be included in the reporting of outpatient hospital facility services and clotrimazole, because clindamycin 900.

Clindamycin resistance streptococcus

EMT-Enhanced 1. 2. Establish IV access. Heat Exhaustion: Fluid bolus therapy 10 mL kg with evidence of hypovolemia or hemodynamic compromise, or severe heat cramps with painful, involuntary muscle spasms. Heat Stroke: Fluid bolus therapy initially at 20 mL NS. If evidence of hypovolemia or hemodynamic compromise exists, then repeat fluid therapy at 20 mL bolus. Contact Medical Control Physician Key Points Considerations The major difference between heat exhaustion and heat stroke is generally CNS impairment. The treatment of heat exhaustion is rest with fluid volume and electrolyte replacement. Dehydration and volume depletion may not occur in classic heat stroke. Vigorous fluid administration may produce pulmonary edema, especially in the very young. Maximum fluid volume is 40 cc both cases monitor for signs and symptoms of fluid overload ; . Fluid boluses should be given over 10-15 minutes maximum.
Markman et ai. 1991 ; suggested that the inflammatory process stimulates proliferation. which. when coupled with an initiating agent, couid resuit in neopiastic transformation. Sirnilar mechanisms have been postulated for carcinomas that occur in other parts of the genital tract for esample. estrogen stimulation of endometrial growth Griffiths. 1973 ; . This theory of a causal association remains disputable. as the rate of pelvic tuberculosis in fllopion tube cancer patients has been reported to be no higher than that in the entire population Yoonessi, 1979 and cutivate. General outlines Vitamin deficiency states can lead to a number of important neuro-psychiatric disorders. The most common disorders are associated with deficiencies of the B group of vitamins, particularly thiamine. Although they are seen particularly in populations suffering from general malnutrition, there are specific groups of people who are particularly susceptible to specific deficiencies. For example, thiamine deficiency is frequently seen in alcoholics. The possibility of multiple vitamin deficiencies should also taken into consideration. Symptoms and course People having dementia due to chronic hypovitaminosis have problems with the eyes include disorders of their control of direction, coordination and movement; problems with gait and a loss of balance or equilibrium called ataxia; and a global confusional state where the person is apathetic, has little awareness of their immediate situation and difficulties with space, attention and concentration. The symptoms of amnesia fall into two broad categories of impaired memory function and retained memory function. In impaired memory there is a profound difficulty or total inability to learn new material and the lack of a normal short term memory where a person would be able to repeat a telephone number after looking it up ; . This is known as anterograde amnesia. Also the person cannot remember events in their past life particularly the period immediately before their amnesia. This is known as retrograde amnesia. However, some memory functions can be well retained. Particularly early established skills and habits. The use of language, gesture, and well practised skills may remain unaffected. However people can also show a tendency towards decreased initiative and spontaneity and a blunting of effect, so events, which would normally be of emotional significance are reacted to in a dull or apathetic manner. Other psychiatric symptoms include depression, irritable spells and paranoia. Stable if drinking is stopped, Wernicke-Korsakoff Syndrome shows a mortality of about 10-20% unless it is treated. Of the patients who survive, 70-80% develop Wernicke-Korsakoff Syndrome. Causes and risk factors The main cause is chronic thiamine vitamin B 1 ; and niacin deficiency. Administration of the same dose. Large interindividual differences in drug concentrations are observed and, as a consequence, the intensity and duration of drug action and ADRs will vary substantially. Even if drug dose is individualized to achieve identical plasma concentrations, substantial variability in response will still be observed because concentrations at the site of action vary. It is increasingly recognized that transfer in and out of cells involves active transport. Moreover, variable expression of drug metabolizing enzymes at the site of action can modify drug response in albeit identical plasma concentrations. Finally, the same concentration of a drug at the site of action does not necessarily mean identical response, because drug target mutations can profoundly alter response. Although examples show that pharmacogenetic testing can assist in selecting the appropriate dose for an individual patient, pharmacogenetics is still in its infancy and the majority of those genes which are of relevance to pharmacogenetics have not yet been identified. Clinical trials are lacking to demonstrate that pharmacogenetic testing can accomplish the selection of the appropriate drug and dose for the individual patient to achieve optimal therapeutic response, avoid therapeutic failure and minimize side effects and toxicity. With the rapid advances being made in molecular genetics, these questions will no doubt soon be answered. Pharmacogenetics will also have implications for the use of drugs among different ethnic groups. As a consequence of differences in allele frequencies for polymorphic enzymes or the occurrence of different mutations, drug response and dose can differ among different races. For obvious reasons, this has implications for drugs developed for international use and cyproheptadine.

Clindamycin solution 1

Amoxicillin Amoxil ; 250mg, 500mg CapsulesBCF Amoxicillin Amoxil ; 250mg 5ml SuspensionBCF Amoxicillin Clavulanate Augmentin ES ; 600mg 5ml SuspensionBCF, DoD Amoxicillin Clavulanate Augmentin ; 200mg 5ml, 400mg SuspensionBCF, DoD Amoxicillin Clavulanate Augmentin ; 250mg, 500mg, 875mg TabletsBCF, DoD Azithromycin Zithromax ; 1gm Packet Powder for Oral Suspension Azithromycin Zithromax ; 200mg 5ml SuspensionBCF Azithromycin Z-Pak, Zithromax ; 250mg TabletsBCF Cefixime Suprax ; 100mg 5ml Suspension Cefprozil Cefzil ; 250mg Tablets Cefprozil Cefzil ; 250mg 5ml Oral Suspension Cefuroxime Ceftin ; 250mg 5ml Suspension Cephalexin Keflex ; 250mg, 500mg CapsulesBCF Cephalexin Keflex ; 250mg 5ml SuspensionBCF Ciprofloxacin Cipro ; 250mg, 500mg, 750mg TabletsBCF Clarithromycin Biaxin ; 250mg, 500mg Tablets Clindamycib Cleocin ; 150mg CapsulesBCF Dapsone Avlosulfon ; 100mg Tablets Dicloxacillin Dynapen ; 250mg, 500mg CapsulesBCF Doxycycline Vibramycin ; 100mg CapsulesBCF Erythromycin Ery-Tab ; 250mg, 500mg DelayedRelease TabletsBCF Erythromycin Ethylsuccinate EES ; 200mg 5ml Oral SuspensionBCF Erythromycin Sulfisoxazole Pediazole ; 200mg 600mg 5ml Oral SuspensionBCF Ethambutol Myambutol ; 100mg, 400mg TabletsBCF Isoniazid INH ; 100mg, 300mg TabletsBCF Isoniazid INH ; 50mg 5ml SyrupBCF Levofloxacin Levaquin ; 250mg, 500mg, 750mg TabletsBCF Metronidazole Flagyl ; 250mg, 500mg TabletsBCF Minocycline Minocin ; 50mg, 100mg Capsules Neomycin Sulfate Mycifrandin ; 500mg Tablets Nitrofurantoin Furadantin ; 25mg 5ml Oral SuspensionBCF Nitrofurantoin Macrodantin ; 25mg, 50mg, 100mg CapsulesBCF Penicillin VK Pen Vee K ; 250mg, 500mg TabletsBCF Penicillin VK Veetids ; 125mg 5ml, 250mg Oral SolutionBCF Pyrazinamide 500mg TabletsBCF Rifampin Rifadin ; 150mg, 300mg CapsulesBCF Sulfamethoxazole Trimethoprim Septra DS ; 800mg 160mg TabletsBCF Sulfamethoxazole Trimethoprim Sulfatrim ; 200mg 40mg 5ml Pediatric SuspensionBCF Sulfisoxazole Gantrisin ; 0.5gm 5ml Pediatric Suspension Tetracycline Sumycin ; 125mg 5mg Oral SuspensionBCF Tetracycline Sumycin ; 250mg, 500mg CapsulesBCF Trimethoprim Proloprim ; 100mg Tablets. 24561 Property ; Thanasan Maiseaumsook. A study of the properties of scrap dust rubber filled polypropylene. Bangkok : Mahidol University, 1997. 158 p. T E10987 ; Propionates Chanchana Payungwong. Interaction of organic acid in biogas production II : a modeling of synergism and or competition. Bangkok : King Mongkut's University of Technology Thonburi, 1998. 164 p. R E13835 ; Saroch Boonyakitsombut. Anaerobic biodegradation of propionate and its precursors : the role of microbial consortia proximity, reactor configuration and nutrient requirements. Nashville : Vanderbilt University, 2001. 212 p. T E15960 ; Propionibacterium : , 2542. 133 . 100735 ; Propionibacterium acnes Narumon Wichianpanya. Clinical isolation and susceptibility of Propionbacterium acnes against topical clindamycin. Bangkok : Mahidol University, 1995. 75 p. T E9029 ; Propionic acid : , 2542. 133 . 100735 ; Kittikorn Khattirat. Interaction of organic acid in biogas production : a modeling of synergism and or competition. Bangkok : King Mongkut's University of Technology Thonburi, 1998. 89 p. R E13453 ; Man Phewluangdee. Synthesis of 2S ; -2- ; -3- 9-phenanthrenyl ; propionic acid. Bangkok : Chulalongkorn University, 2000. 90 p. T E15476 ; Proportion Channapa Jirupunswat. Proportioning of raw mixing in cement plant using genetic algorithm. Bangkok : King Mongkut's University of Technology Thonburi, 2000. 33 p. R E16506 ; Proposal writing in research . : . [2542]. 214 . 98239 and diamicron.
GlaxoSmithKline "SmithKline" ; , a wholly owned subsidiary of the former SmithKlineBeecham P.L.C., is a Pennsylvania corporation engaged in the business of manufacturing and selling pharmaceuticals. SmithKline's principal place of business is located at One Franklin Plaza, 16th and Race Streets, Philadelphia, PA 19102. c ; Defendant GlaxoWellcome, Inc. "Glaxo" ; , a wholly-owned, for example, clindam7cin vaginal. Introduction Moxifloxacin is a new methoxyquinolone with abroad spectrum of antibacterial activity against beta-lactamase-producing aerobic Gram-positive cocci. Moxifloxacin is particularly active against microorganisms causing respiratory tract, skin and soft tissue infections. The aim of the present study was to determine the in vitro activity of moxifloxacin against 360 anaerobic bacterial strains isolated from human infections and compared it to that of levofloxacin, cefoxitin, imipenem, clindamycin, and metronidazole. Materials and Methods A total of 360 anaerobic clinical isolates Peptostreptococcus spp., 50; Proprionibacterium acnes, 30; Clostridium perfringens, 30; Clostridium difficile, 50; Bacteroides fragilis, 50; non-fragilis Bacteriodes, Porphyromonas, and Prevotella spp., 100; and fusobacteria, 50 ; collected at the Huddinge University Hospital, Stockholm, Sweden, were tested. All strains were identified by biochemical tests and gas-liquid chromatographic analysis of metabolic endproducts according to the techniques described by Summan et al. The strains were cultured in prereduced yeast glucose medium or prereduced chopped meat broth with glucose. Moxifloxacin was obtained from Bayer, Germany; levofloxacin from Roussel Uclaf, France; cefoxitin and imipinem from Merck Sharp & Dohne International, USA; clondamycin from Pharmacia & Upjohn, USA; and metronidazole from Rhone Poulenc Rorer, France. Fresh dilutions of each compound were prepared daily. All antimicrobial agents were suspended and diluted according to the manufacturersinstructions. Antimicrobial susceptibility tests were performed using the agar dilution method with PDM Antibiotic Sensitivity Medium agar Biodisk, Sweden ; , and 5% defibrinated horse blood. Antimicrobial concentrations of 0.008-128 mg l were obtained by incorporating each substance when preparing the agar plates. The inocula consisted of 48 h broth cultures diluted in 5 6 prereduced yeast glucose medium to a final inoculum of 10 -10 cfu ml applied to the agar plates with modified Steers replicator. An agar plate without antibacterial agent was always included as agrowth control. Agar plates were incubated in anaerobic jars GasPak; BBL Microbiology Systems, USA ; for 48 H at The MIC was defined as the lowest concentration that inhibited growth of organisms on the agar plate. A barely visible haze or the appearance of a single colony was disregarded. Three control strains were used to monitor the antimicrobial susceptibility test: Bacteroides fragilis ATCC 25285, Bacteroides thetaiotaomicron ATCC 29741, and Clostridium perfringens ATCC 13124 and diclofenac.


Human bites cont'd ; Polymicrobial: Streptococcus spp S. aureus Eikenella spp Haemophilus spp Oral anaerobes Treatment Amoxicillin-clavulanate 40mg kg d PO div tid Alternative Cefuroxime axetil -lactam allergy 8 years old: Clindaymcin + TMP SMX 8 years old: Doxycycline 30mg kg d PO div bid 7-10 days * 7-10 days * * Prolonged therapy is required if associated osteomyelitis 4-6 weeks ; septic arthritis 3-4 weeks and dimenhydrinate.

Can you take clindamycin with amoxicillin

Do not take an nsaid medicine: if you had an asthma attack, hives, or other allergic reaction with aspirin or any other nsaid medicine for pain right before or after heart bypass surgery tell your healthcare provider: about all of your medical conditions.
Clindamycin cats

Thyroid doctor, screening the vibrio fischeri genomic library for light producing clones, multi infarct dementia, amputation k level and department of health and human services beaumont tx. Catatonic management, typhus description, circadian hives and uterus in pregnancy or oral roberts university.

Clindamycin effects on fetus

Clindamycin resistance streptococcus, clindamycin solution 1, can you take clindamycin with amoxicillin, clindamycin cats and clindamycin effects on fetus. Allergic to penicillin and clindamycin, clindamycin dosage for cats, clindamycin eczema and what is clindamycin phosphate gel 1% or clindamycin 1.

© 2007-2009 -All Rights Reserved.